Scandinavian Biolabs ApS — Credit Rating and Financial Key Figures
CVR number: 41170514
Kronprinsessegade 54, 1306 København K
nk@scandinavianbiolabs.com
tel: 70605708
www.scandinavianbiolabs.com
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | -1 145.35 | -1 883.46 | 1 591.10 | 5 116.00 | - 518.95 |
Employee benefit expenses | - 629.90 | -2 691.86 | -4 006.26 | -5 949.89 | -7 166.10 |
Total depreciation | -4.65 | -13.93 | |||
EBIT | -1 779.90 | -4 589.25 | -2 415.15 | - 833.89 | -7 685.05 |
Other financial income | 0.09 | 3.22 | 88.49 | 16.49 | 55.56 |
Other financial expenses | -1.49 | -26.09 | - 189.16 | - 536.16 | -1 143.86 |
Pre-tax profit | -1 781.31 | -4 612.12 | -2 515.83 | -1 353.56 | -8 773.34 |
Net earnings | -1 781.31 | -4 612.12 | -2 515.83 | -1 353.56 | -8 773.34 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Intangible assets total | |||||
Machinery and equipment | 13.93 | ||||
Tangible assets total | 13.93 | ||||
Holdings in group member companies | 6.84 | ||||
Investments total | 50.00 | 50.00 | 50.00 | 86.02 | |
Long term receivables total | |||||
Semifinished products | 633.71 | 705.57 | |||
Raw materials and consumables | 587.51 | 1 486.91 | |||
Finished products/goods | 260.98 | 824.41 | 1 274.74 | 3 884.20 | 7 513.98 |
Advance payments | 241.66 | 165.38 | |||
Inventories total | 260.98 | 1 458.12 | 1 980.31 | 4 713.36 | 9 166.26 |
Current trade debtors | 116.45 | 604.28 | 1 239.06 | 2 653.15 | 2 589.20 |
Current amounts owed by group member comp. | 74.56 | ||||
Prepayments and accrued income | 288.05 | 86.21 | 586.96 | ||
Current other receivables | 112.25 | 1 622.18 | 2 966.85 | ||
Short term receivables total | 116.45 | 892.33 | 1 437.51 | 4 275.34 | 6 217.57 |
Cash and bank deposits | 87.22 | 144.10 | 223.84 | 3 842.21 | 18 825.13 |
Cash and cash equivalents | 87.22 | 144.10 | 223.84 | 3 842.21 | 18 825.13 |
Balance sheet total (assets) | 478.57 | 2 544.54 | 3 691.66 | 12 880.90 | 34 294.98 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Share capital | 40.00 | 2 933.33 | 2 933.33 | 3 141.35 | 4 326.47 |
Retained earnings | -1 735.75 | -6 347.87 | -3 071.72 | 22 017.83 | |
Profit of the financial year | -1 781.31 | -4 612.12 | -2 515.83 | -1 353.56 | -8 773.34 |
Shareholders equity total | -1 741.31 | -3 414.54 | -5 930.37 | -1 283.92 | 17 570.96 |
Non-current liabilities total | |||||
Current loans from credit institutions | 1 091.15 | 1 268.47 | |||
Current trade creditors | 2 519.03 | 3 889.35 | 6 973.33 | 9 957.60 | |
Current owed to participating | 2 267.62 | ||||
Current owed to group member | 1 500.00 | 559.32 | 3 661.76 | 4 371.26 | |
Other non-interest bearing current liabilities | 719.88 | 1 789.58 | 350.21 | 2 820.24 | 4 498.81 |
Accruals and deferred income | 452.24 | ||||
Current liabilities total | 2 219.88 | 5 959.08 | 9 622.03 | 14 164.83 | 16 724.03 |
Balance sheet total (liabilities) | 478.57 | 2 544.54 | 3 691.66 | 12 880.90 | 34 294.98 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.